This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Fatty acid amide hydrolase in major depressive episodes: A [11C]CURB positron emission tomography study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
CB1 Receptor Negative Allosteric Modulators as a Potential Tool to Reverse Cannabinoid Toxicity.
Molecules (Basel, Switzerland) · 2024
Evidence that cannabinoid CB1 receptors regulate intraocular pressure via two opposing mechanisms.
Experimental eye research · 2020
Latest funding
- $921,826
The role of the endocannabinoid 2AG in high dopamine states: implications of pharmacological manipulation
CIHR · 2025 · Nominated PI
- $10,000
Cannabis and Cannabinoids: From Plant to Policy
CIHR · 2022 · Co-investigator
- $765,000
Development and Characterization of Novel CB1 Allosteric Modulators
CIHR · 2020 · Nominated PI
9 publications.
Fatty acid amide hydrolase in major depressive episodes: A [11C]CURB positron emission tomography study.
Rafiei D, De Pol M, Meyer JH, Desmond K, Ross R, Boileau I, Warsh J, Rusjan P, Vasdev N, Aloysius R, Gray L, Kolla NJ
CB1 Receptor Negative Allosteric Modulators as a Potential Tool to Reverse Cannabinoid Toxicity.
Flavin A, Azizi P, Murataeva N, Yust K, Du W, Ross R, Greig I, Nguyen T, Zhang Y, Mackie K, Straiker A
Evidence that cannabinoid CB1 receptors regulate intraocular pressure via two opposing mechanisms.
Miller S, Daily L, Ploss M, Greig I, Ross R, Rayana NP, Dai J, Sugali CK, Mao W, Straiker A
Disease-associated polymorphisms within the conserved ECR1 enhancer differentially regulate the tissue-specific activity of the cannabinoid-1 receptor gene promoter; implications for cannabinoid pharmacogenetics.
Hay EA, Cowie P, McEwan AR, Ross R, Pertwee RG, MacKenzie A
Enantiomer-specific positive allosteric modulation of CB1 signaling in autaptic hippocampal neurons.
Mitjavila J, Yin D, Kulkarni PM, Zanato C, Thakur GA, Ross R, Greig I, Mackie K, Straiker A
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives.
Lazzari P, Distinto R, Manca I, Baillie G, Murineddu G, Pira M, Falzoi M, Sani M, Morales P, Ross R, Zanda M, Jagerovic N, Pinna GA
The promise and peril of chemical probes.
Arrowsmith CH, Audia JE, Austin C, Baell J, Bennett J, Blagg J, Bountra C, Brennan PE, Brown PJ, Bunnage ME, Buser-Doepner C, Campbell RM, Carter AJ, Cohen P, Copeland RA, Cravatt B, Dahlin JL, Dhanak D, Edwards AM, Frederiksen M, Frye SV, Gray N, Grimshaw CE, Hepworth D, Howe T, Huber KV, Jin J, Knapp S, Kotz JD, Kruger RG, Lowe D, Mader MM, Marsden B, Mueller-Fahrnow A, Müller S, O'Hagan RC, Overington JP, Owen DR, Rosenberg SH, Roth B, Ross R, Schapira M, Schreiber SL, Shoichet B, Sundström M, Superti-Furga G, Taunton J, Toledo-Sherman L, Walpole C, Walters MA, Willson TM, Workman P, Young RN, Zuercher WJ
Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459.
Goonawardena AV, Plano A, Robinson L, Ross R, Greig I, Pertwee RG, Hampson RE, Platt B, Riedel G
Prescribing contraceptives for women with schizophrenia.
Seeman MV, Ross R
The role of the endocannabinoid 2AG in high dopamine states: implications of pharmacological manipulation
Principal investigators: Ross, Ruth A
Keywords: Cannabinoid; Dopamine; Pharmacology
Cannabis and Cannabinoids: From Plant to Policy
Principal investigators: Hill, Matthew N
Keywords: Cannabinoid; Cannabis; Endocannabinoid; Inflammatory Disease; Mental Health; Neurology; Neuroscience; Pharmacology; Physician; Public Health
Development and Characterization of Novel CB1 Allosteric Modulators
Principal investigators: Ross, Ruth A
Keywords: Cannabinoid; Drug Discovery; Mental Health
Functional Genomics of Neurodegenerative Diseases: Defining Molecular Pathogenesis and Targets for Biomarkers and Personalised Therapies
Principal investigators: ST GEORGE-HYSLOP, Peter H
Keywords: Alzheimer Disease; Biomarkers; Frontotemporal Lobar Degeneration; Functional Genetics Of Risk Genes; Intrinsically Disordered Phase Separating Proteins; Neurological Disorders; Therapeutic Targets
Development and therapeutic validation of GPR55 modulators for the treatment of osteoclast-mediated disorders
Principal investigators: Ross, Ruth A
Keywords: Bone; Cancer; Cannabinoid; Drug Discovery
Development and Commercialisation of Allosteric Modulators for the Treatment of Pain
Principal investigators: Ross, Ruth A
Keywords: Drug Discovery; Pain
Development and Testing of Small Molecule Allosteric Modulators for the Treatment of Pain.
Principal investigators: Ross, Ruth A
Keywords: Allosteric; Cannabinoid; Drug Discovery; Pain
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Neil Vasdev and Isabelle Boileau: 13 shared papers
- Isabelle Boileau and Pablo Rusjan: 6 shared papers
- Neil Vasdev and Pablo Rusjan: 5 shared papers
- Ruth Ross and Neil Vasdev: 1 shared paper
- Ruth Ross and Isabelle Boileau: 1 shared paper
- Ruth Ross and Pablo Rusjan: 1 shared paper
- Ruth Ross and Matthieu Schapira: 1 shared paper
- Pharmacology and Toxicology
- Structural Genomics Consortium
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.